Clinical Research Directory

Inclusion Criteria: * Able to provide written informed consent prior to performing any protocol-related procedures, including screening. * Adults (≥18 years) with confirmed diagnosis of inflammatory skin disease (defined as any skin disease with an inflammatory component, including but not limited to, genetic skin disease, such as EB), OR * Adults age (≥18 years) without skin or systemic disease. Exclusion Criteria: * Inability to give written informed consent. * Participants who have received topical corticosteroids to sites of biopsies (inflamed area of skin) for at least 2 weeks prior to tissue sampling. * Inability to participate in study-specific procedures. * Participants who are pregnant (confirmed on a positive urine pregnancy test) or breastfeeding * Enrolment in any interventional study with systemic treatment within 3 months prior to baseline biopsy.